Floatz logo

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE

Chronic Postoperative Pain

Imperial College Healthcare NHS TrustSmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Chronic Postoperative Pain cohort.

Asset / SponsorPhaseRating
Bxcl501
Zhongda Hospital
Phase 4BB
Pregabalin
Unity Health Toronto
Phase 4BB
Buprenorphine
Medical University of Silesia
Phase 4BB
Oxycodone
Medical University of Silesia
Phase 4BB
ROPIVACAINE
Xijing Hospital
Early Phase 1CCC

View all 16 →

Same molecule, other indications

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE is also rated in:

major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →